Get the Stockscreener App
1.55
2.52%
-0.04
Camp 4 Therapeutics Corp stock is traded at $1.55, with a volume of 58,577.
It is down -2.52% in the last 24 hours and down -7.19% over the past month.
Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.
See More
Previous Close:
$1.59
Open:
$1.62
24h Volume:
58,577
Relative Volume:
0.45
Market Cap:
$31.25M
Revenue:
$264.74M
Net Income/Loss:
$-49.71M
P/E Ratio:
-0.3784
EPS:
-4.0959
Net Cash Flow:
$-43.55M
1W Performance:
-7.19%
1M Performance:
-7.19%
6M Performance:
-67.78%
1Y Performance:
+287.50%
1-Day Range:
$1.55
$1.67
1-Week Range:
$1.50
$1.94
52-Week Range:
$1.305
$12.30
Camp 4 Therapeutics Corp Stock (CAMP) Company Profile
Name
Camp 4 Therapeutics Corp
Sector
Industry
Phone
617-651-8867
Address
ONE KENDALL SQUARE, CAMBRIDGE, CA
Compare CAMP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAMP
Camp 4 Therapeutics Corp
|
1.55 | 37.49M | 264.74M | -49.71M | -43.55M | -4.0959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Camp 4 Therapeutics Corp Stock (CAMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Initiated | Wedbush | Outperform |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | Piper Sandler | Overweight |
| Nov-05-24 | Initiated | William Blair | Outperform |
| Aug-16-22 | Upgrade | Craig Hallum | Hold → Buy |
| Dec-22-21 | Downgrade | Craig Hallum | Buy → Hold |
| Sep-24-21 | Reiterated | Craig Hallum | Buy |
| Jun-25-21 | Reiterated | Craig Hallum | Buy |
| Dec-18-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Apr-17-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-05-20 | Reiterated | Craig Hallum | Buy |
| Dec-20-19 | Reiterated | Craig Hallum | Buy |
| Dec-20-19 | Downgrade | First Analysis Sec | Outperform → Neutral |
| Jun-28-19 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-29-19 | Downgrade | Goldman | Neutral → Sell |
| May-01-19 | Reiterated | Craig Hallum | Buy |
| Mar-25-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-25-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-21-18 | Upgrade | Craig Hallum | Hold → Buy |
| Dec-14-18 | Reiterated | B. Riley FBR | Buy |
| Dec-11-18 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Dec-11-18 | Downgrade | Northland Capital | Outperform → Market Perform |
| Nov-27-18 | Initiated | Goldman | Neutral |
| Oct-15-18 | Initiated | Jefferies | Hold |
| Sep-28-18 | Reiterated | Craig Hallum | Hold |
| Apr-27-18 | Reiterated | Craig Hallum | Hold |
| Mar-08-18 | Downgrade | Craig Hallum | Buy → Hold |
| Feb-16-18 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
View All
Camp 4 Therapeutics Corp Stock (CAMP) Latest News
Key resistance and support levels for Camp4 Therapeutics CorporationTrade Risk Summary & Long-Term Capital Growth Ideas - Newser
Is Camp4 Therapeutics Corporation meeting your algorithmic filter criteriaWeekly Profit Summary & AI Driven Stock Price Forecasts - Newser
Is this a good reentry point in Camp4 Therapeutics CorporationJuly 2025 Closing Moves & Long-Term Capital Growth Strategies - Newser
What recovery options are there for Camp4 Therapeutics CorporationMarket Weekly Review & Weekly Stock Performance Updates - Newser
Is Camp4 Therapeutics Corporation stock bottoming out2025 Key Highlights & Detailed Earnings Play Alerts - Newser
How to read the order book for Camp4 Therapeutics Corporation2025 Key Highlights & Safe Entry Zone Tips - Newser
Will breakout in Camp4 Therapeutics Corporation lead to full recoveryMarket Trend Review & Step-by-Step Trade Execution Guides - Newser
Analyzing recovery setups for Camp4 Therapeutics Corporation investorsWeekly Loss Report & Consistent Return Investment Signals - Newser
Is it time to cut losses on Camp4 Therapeutics CorporationMarket Risk Summary & Daily Entry Point Trade Alerts - Newser
Applying Elliott Wave Theory to Camp4 Therapeutics CorporationM&A Rumor & Verified Swing Trading Watchlists - Newser
Published on: 2025-08-19 22:15:01 - Newser
Predicting Camp4 Therapeutics Corporation trend using moving averagesJobs Report & Risk Controlled Swing Alerts - Newser
Advanced analytics toolkit walkthrough for Camp4 Therapeutics CorporationWeekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser
Institutional scanner results for Camp4 Therapeutics Corporation2025 Earnings Impact & Momentum Based Trading Ideas - Newser
What moving averages say about Spero Therapeutics Inc.July 2025 Momentum & Short-Term High Return Strategies - Newser
Leading vs lagging indicators on CleanCore Solutions Inc. performance2025 AllTime Highs & Intraday High Probability Alerts - Newser
How to build a custom watchlist for Nova LifeStyle Inc.July 2025 PostEarnings & Risk Managed Investment Entry Signals - Newser
Is now a turning point for Dragonfly Energy Holdings Corp.July 2025 Breakouts & Daily Volume Surge Signals - Newser
Combining machine learning predictions for IGHGJuly 2025 Retail & Daily Oversold Bounce Ideas - Newser
Is Camp4 Therapeutics Corporation likely to announce a buyback2025 Market Trends & Stock Timing and Entry Methods - thegnnews.com
Does Hillenbrand Inc. fit your quant trading modelMarket Risk Summary & Capital Protection Trade Alerts - Newser
How to build a dashboard for BK Technologies Corporation stock2025 Buyback Activity & Weekly Return Optimization Alerts - Newser
Technical signs of recovery in KINDInsider Selling & Real-Time Stock Movement Alerts - Newser
How sentiment analysis helps forecast Camp4 Therapeutics Corporation - Newser
Alternative Income TrustJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - Newser
Signal strength of BAC.PRK stock in tech scannersQuarterly Earnings Summary & Capital Efficient Trading Techniques - Newser
Smart tools for monitoring PATH’s price actionExit Point & Momentum Based Trading Ideas - Newser
Risk vs reward if holding onto Camp4 Therapeutics CorporationWeekly Trend Summary & Comprehensive Market Scan Insights - Newser
Using Ichimoku Cloud for MOLN technicalsWeekly Trend Summary & Fast Gaining Stock Strategy Reports - Newser
Will Grayscale Bitcoin Mini Trust benefit from green energy policies2025 Top Decliners & AI Powered Buy and Sell Recommendations - sundaytimes.kr
Can Camp4 Therapeutics Corporation Escape Recent Bear ChannelTrade Analysis Summary & Verified Short-Term Plans - sundaytimes.kr
Real time scanner hits for SCHW.PRJ explainedJuly 2025 Analyst Calls & Real-Time Market Sentiment Reports - Newser
Visual analytics tools that track Heritage Commerce Corp performanceMarket Activity Recap & Precise Swing Trade Entry Alerts - Newser
Detecting support and resistance levels for MCBSRate Cut & Community Trade Idea Sharing - Newser
What moving averages say about Mueller Industries Inc.Trade Analysis Summary & Weekly Stock Breakout Alerts - Newser
Camp 4 Therapeutics Corp Stock (CAMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Camp 4 Therapeutics Corp Stock (CAMP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| AH Equity Partners Bio I, L.L. | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
727,272 |
7,999,992 |
1,579,885 |
| Enavate Sciences GP, LLC | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
1,363,636 |
14,999,996 |
3,785,802 |
| Polaris Management Co. VII, L. | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
909,090 |
| 5AM Partners VI, LLC | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
2,625,145 |
| Nashat Amir | Director |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
909,090 |
| Schwab Andrew J. | Director |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
2,625,145 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):